Show simple item record

dc.contributor.authorVegas Suárez, Sergio ORCID
dc.contributor.authorAristieta Arbelaiz, Asier
dc.contributor.authorRequejo Rodríguez, Catalina ORCID
dc.contributor.authorBengoetxea Odriozola, Harkaitz
dc.contributor.authorLafuente Sánchez, José Vicente ORCID
dc.contributor.authorMiguélez Palomo, Cristina
dc.contributor.authorUgedo Urruela, Luisa
dc.date.accessioned2021-06-11T10:21:13Z
dc.date.available2021-06-11T10:21:13Z
dc.date.issued2021-06
dc.identifier.citationBritish Journal Of Pharmacology 178(12) : 2516-2532 (2021)es_ES
dc.identifier.issn0007-1188
dc.identifier.issn1476-5381
dc.identifier.urihttp://hdl.handle.net/10810/51844
dc.description.abstractBackground and Purpose l-DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5-HT1A receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the etiopathology of l-DOPA-induced dyskinesia, we investigated whether the entopeduncular nucleus is modulated by the 5-HT1A receptor partial and full agonists, buspirone, and 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) in control and 6-hydroxydopamine (6-OHDA)-lesioned rats with or without long-term l-DOPA treatment. Experimental Approach Extracellular single-unit electrocorticogram and local field potential recordings under anaesthesia, immunostaining assays and optogenetic manipulation coupled to electrophysiological recordings were performed. Key Results Systemic buspirone reduced the entopeduncular nucleus firing rate in the sham animals and burst activity in the 6-OHDA-lesioned rats (with or without l-DOPA treatment), while local administration reduced entopeduncular nucleus activity in all the groups, regardless of DA integrity. Systemic 8-OH-DPAT also induced inhibitory effects only in the sham animals. Effects triggered by buspirone and 8-OH-DPAT were reversed by the 5-HT1A receptor antagonist, WAY-100635. Neither buspirone nor 8-OH-DPAT modified the low-frequency oscillatory activity in the entopeduncular nucleus or its synchronization with the motor cortex. Buspirone did not alter the response induced by subthalamic nucleus opto-stimulation in the entopeduncular nucleus. Conclusion and Implications Systemic 5-HT1A receptor activation elicits different effects on the electrophysiological properties of the entopeduncular nucleus depending on the integrity of the nigrostriatal pathway and it does not alter the relationship between subthalamic nucleus and entopeduncular nucleus neuron activity.es_ES
dc.description.sponsorshipEuskal Herriko Unibertsitatea, Grant/Award Number: GIU19/092; Basque Government, Grant/Award Numbers: PIBA 2019-38, T747-13; Spanish Ministry of Economy and Competitiveness, Grant/Award Number: SAF2016-77758-R AEI/FEDER, UEes_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/SAF2016-77758-Res_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subject8-OH-DPATes_ES
dc.subjectbasal gangliaes_ES
dc.subjectbuspironees_ES
dc.subjectdyskinesiaes_ES
dc.subjectelectrophysiologyes_ES
dc.subjectParkinson's diseasees_ES
dc.subject5-hyroxytryptaminees_ES
dc.subjectserotonines_ES
dc.subjecthigh-frequency stimulationes_ES
dc.subjectdeep brain-stimulationes_ES
dc.subjectabnormal involuntary movementses_ES
dc.subjectdopa-induced dyskinesiaes_ES
dc.subjectdorsal raphe nucleuses_ES
dc.subjectglobus-palliduses_ES
dc.subjectnigrostriatal pathwayes_ES
dc.subjectparkinsons-diseasees_ES
dc.subjectbasal gangliaes_ES
dc.titleThe Effect of 5-HT1A Receptor Agonists on the Entopeduncular Nucleus is Modified in 6-Hydroxydopamine-Lesioned Ratses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holderThis is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0)es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.15437es_ES
dc.identifier.doi10.1111/bph.15437
dc.departamentoesFarmacologíaes_ES
dc.departamentoesNeurocienciases_ES
dc.departamentoeuFarmakologiaes_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0)
Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0)